ENTASIS THERAPEUTICS HOLDINGS INC. Shareholders' Equity
ENTASIS THERAPEUTICS HOLDINGS INC. had Shareholders' Equity of $16.65 million as of 2022-03-31, per its 10-Q filed 2022-04-27.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2022-04-27
- 2022-03-31: Stockholders' Equity Attributable to Parent $16.65M.
- 2021-12-31: Stockholders' Equity Attributable to Parent $31.21M.
- 2021-09-30: Stockholders' Equity Attributable to Parent $41.23M.
- 2021-06-30: Stockholders' Equity Attributable to Parent $53.06M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2022-03-31 | $16.65M 10-Q · filed 2022-04-27 |
| 2021-12-31 | $31.21M 10-Q · filed 2022-04-27 |
| 2021-09-30 | $41.23M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $53.06M 10-Q · filed 2021-11-04 |
| 2021-03-31 | $44.26M 10-Q · filed 2022-04-27 |
| 2020-12-31 | $52.29M 10-Q · filed 2022-04-27 |
| 2020-09-30 | $62.24M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $49.29M 10-Q · filed 2021-11-04 |
| 2020-03-31 | $27.70M 10-Q · filed 2021-08-12 |
| 2019-12-31 | $42.16M 10-K · filed 2022-03-03 |
| 2019-09-30 | $54.89M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $57.84M 10-Q · filed 2020-11-05 |
| 2019-03-31 | $70.57M 10-Q · filed 2020-08-06 |
| 2018-12-31 | $82.88M 10-K/A · filed 2021-04-30 |
| 2018-09-30 | $90.48M 10-Q · filed 2019-11-14 |
| 2018-06-30 | -$71.72M 10-Q · filed 2019-11-14 |
| 2018-03-31 | -$66.30M 10-Q · filed 2019-08-12 |
| 2017-12-31 | -$55.79M 10-K · filed 2020-03-11 |
| 2016-12-31 | -$26.34M 10-K · filed 2019-03-29 |